BIOLOGICS, NEWS
The Alzheimer’s Association reports that nearly 4 in 5 older Americans would want to know if they had Alzheimer’s disease before having symptoms, or before those symptoms interfered with their activities. They also want treatment, even if it comes with risks, as long...
NEWS
On Monday, Donald J. Trump was inaugurated as the 47th U.S. president, leading many in the biotech and pharmaceutical sectors to speculate on what impacts the second Trump administration will have on their industries. Back in December, an article in Biospace by...
BIOLOGICS, NEWS
As widely reported, earlier this week FDA approved the first in a novel class of immuno-oncology drugs called bispecific T-cell engagers for the treatment of small cell carcinoma. Small cell carcinoma, an aggressive type of lung cancer, currently has a few effective...
NEWS
Researchers at Fudan University in Shanghai have identified four blood proteins that could serve as early biomarkers for dementia. This is important news because early, pre-symptomatic diagnosis of Alzheimer’s and other forms of dementia could be a big step in...
BIOLOGICS, NEWS
We are so happy to learn that the IPO of our former client CG Oncology went exceedingly well. After recent news that GC Oncology’s bladder cancer treatment received both FDA fast track and breakthrough therapy designation, this is more good news for people with...
NEWS
Gabapentin is a widely prescribed non-opioid painkiller, but it has many side effects, including memory loss, mood changes, and lethargy. New research out of NYU shows promise for a small molecule called CBD3063*, which in rodents has been shown to inhibit pain at...
